These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 16099719

  • 1. Genetic susceptibility and immune-mediated destruction in beryllium-induced disease.
    Fontenot AP, Maier LA.
    Trends Immunol; 2005 Oct; 26(10):543-9. PubMed ID: 16099719
    [Abstract] [Full Text] [Related]

  • 2. T cell recognition in chronic beryllium disease.
    Amicosante M, Fontenot AP.
    Clin Immunol; 2006 Nov; 121(2):134-43. PubMed ID: 16697706
    [Abstract] [Full Text] [Related]

  • 3. Metal-induced diffuse lung disease.
    Fontenot AP, Amicosante M.
    Semin Respir Crit Care Med; 2008 Dec; 29(6):662-9. PubMed ID: 19221964
    [Abstract] [Full Text] [Related]

  • 4. Chronic beryllium disease: immune-mediated destruction with implications for organ-specific autoimmunity.
    Fontenot AP, Kotzin BL.
    Tissue Antigens; 2003 Dec; 62(6):449-58. PubMed ID: 14617028
    [Abstract] [Full Text] [Related]

  • 5. Linking genetic susceptibility and T cell activation in beryllium-induced disease.
    Falta MT, Bowerman NA, Dai S, Kappler JW, Fontenot AP.
    Proc Am Thorac Soc; 2010 May; 7(2):126-9. PubMed ID: 20427584
    [Abstract] [Full Text] [Related]

  • 6. Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease.
    Fontenot AP, Torres M, Marshall WH, Newman LS, Kotzin BL.
    Proc Natl Acad Sci U S A; 2000 Nov 07; 97(23):12717-22. PubMed ID: 11050177
    [Abstract] [Full Text] [Related]

  • 7. T cell recognition of beryllium.
    Dai S, Falta MT, Bowerman NA, McKee AS, Fontenot AP.
    Curr Opin Immunol; 2013 Dec 07; 25(6):775-80. PubMed ID: 23978481
    [Abstract] [Full Text] [Related]

  • 8. Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II beta-chain.
    Bill JR, Mack DG, Falta MT, Maier LA, Sullivan AK, Joslin FG, Martin AK, Freed BM, Kotzin BL, Fontenot AP.
    J Immunol; 2005 Nov 15; 175(10):7029-37. PubMed ID: 16272364
    [Abstract] [Full Text] [Related]

  • 9. Beryllium-induced tumor necrosis factor-alpha production by CD4+ T cells is mediated by HLA-DP.
    Sawyer RT, Parsons CE, Fontenot AP, Maier LA, Gillespie MM, Gottschall EB, Silveira L, Newman LS.
    Am J Respir Cell Mol Biol; 2004 Jul 15; 31(1):122-30. PubMed ID: 14975942
    [Abstract] [Full Text] [Related]

  • 10. Beryllium-Induced Hypersensitivity: Genetic Susceptibility and Neoantigen Generation.
    Fontenot AP, Falta MT, Kappler JW, Dai S, McKee AS.
    J Immunol; 2016 Jan 01; 196(1):22-7. PubMed ID: 26685315
    [Abstract] [Full Text] [Related]

  • 11. Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles.
    Wang Z, White PS, Petrovic M, Tatum OL, Newman LS, Maier LA, Marrone BL.
    J Immunol; 1999 Aug 01; 163(3):1647-53. PubMed ID: 10415070
    [Abstract] [Full Text] [Related]

  • 12. Chronic beryllium disease: a hypersensitivity disorder.
    Rossman MD.
    Appl Occup Environ Hyg; 2001 May 01; 16(5):615-8. PubMed ID: 11370939
    [Abstract] [Full Text] [Related]

  • 13. HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease.
    Lombardi G, Germain C, Uren J, Fiorillo MT, du Bois RM, Jones-Williams W, Saltini C, Sorrentino R, Lechler R.
    J Immunol; 2001 Mar 01; 166(5):3549-55. PubMed ID: 11207315
    [Abstract] [Full Text] [Related]

  • 14. The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization.
    McCanlies EC, Ensey JS, Schuler CR, Kreiss K, Weston A.
    Am J Ind Med; 2004 Aug 01; 46(2):95-103. PubMed ID: 15273960
    [Abstract] [Full Text] [Related]

  • 15. Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease.
    Maier LA, McGrath DS, Sato H, Lympany P, Welsh K, Du Bois R, Silveira L, Fontenot AP, Sawyer RT, Wilcox E, Newman LS.
    J Immunol; 2003 Dec 15; 171(12):6910-8. PubMed ID: 14662898
    [Abstract] [Full Text] [Related]

  • 16. Immunology of chronic beryllium disease.
    Samuel G, Maier LA.
    Curr Opin Allergy Clin Immunol; 2008 Apr 15; 8(2):126-34. PubMed ID: 18317020
    [Abstract] [Full Text] [Related]

  • 17. Beryllium hypersensitivity and chronic beryllium lung disease.
    Santo Tomas LH.
    Curr Opin Pulm Med; 2009 Mar 15; 15(2):165-9. PubMed ID: 19532033
    [Abstract] [Full Text] [Related]

  • 18. Role of the HLA-DP Glu 69 and the TNF-alpha TNF-alpha 2 gene markers in susceptibility to beryllium hypersensitivity.
    Rogliani P, Amicosante M, Berretta F, Dotti C, Bocchino M, O'Donnell KM, Saltini C.
    Int J Immunopathol Pharmacol; 2004 Mar 15; 17(2 Suppl):3-10. PubMed ID: 15345185
    [Abstract] [Full Text] [Related]

  • 19. HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity.
    Rosenman KD, Rossman M, Hertzberg V, Reilly MJ, Rice C, Kanterakis E, Monos D.
    Occup Environ Med; 2011 Jul 15; 68(7):487-93. PubMed ID: 21186201
    [Abstract] [Full Text] [Related]

  • 20. Recent advances in understanding the biomolecular basis of chronic beryllium disease: a review.
    McCleskey TM, Buchner V, Field RW, Scott BL.
    Rev Environ Health; 2009 Jul 15; 24(2):75-115. PubMed ID: 19658317
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.